Bothrombin, a snake-venom serine protease, speci®cally cleaves ®brinogen, releasing ®brinopeptide A to form non-crosslinked soft clots, aggregates platelets in the presence of exogeneous ®brinogen and activates blood coagulation factor VIII. Bothrombin shares high sequence homology with other snake-venom proteases such as batroxobin (94% identity), but only 30 and 34% identity with human -thrombin and trypsin, respectively. Single crystals of bothrombin have been obtained and X-ray diffraction data have been collected at the Laboratorio Nacional de Luz Sincrotron to a resolution of 2.8 A Ê . The crystals belong to the space group P2 1 2 1 2 1 , with unit-cell parameters a = 94.81, b = 115.68, c = 155.97 A Ê .
Introduction
Snake venoms are rich sources of metalloproteases and serine proteases that play key roles in haemorrhagia and blood-clotting disorders (Kornalik, 1990a,b) . The metalloproteases often display haemorrhagic activity, demonstrate low substrate speci®city and are inhibited by metal chelators such as EDTA. On the other hand, the serine proteases display higher substrate speci®city, hydrolyze only speci®c bonds in peptides and are inhibited by DFP and PMSF.
Serine proteases have been isolated and characterized from a number of snake venoms and display a wide spectrum of activities such as cleavage of ®brinogen (Herzig et al., 1970; Aragon-Ortiz & Gubensek, 1981; Iwasaki et al., 1990; Aguiar et al., 1996) , release of bradykinin (Sato et al., 1965) , increase in capillarity and permeability (Sato et al., 1965) , -®brinogenase activity (Ouyang & Teng, 1976; Ouyang et al., 1979) , activation of factor V (Schiffman et al., 1969; Rawala et al., 1978) , thrombin-like platelet activation (Marrakchi et al., 1995) and induction of non-coagulant platelet aggregation (Niewiarowski et al., 1979; Schmaier et al., 1980) . The venom serine proteases are often referred to as thrombin-like proteases since they exhibit ®brinogen-clotting activity and have been the focus of many studies owing to their clinical and biochemical applications. These enzymes are divided into three basic classes depending on their ability to release ®brinopeptide A (class A), ®brinopeptide B (class B) or both ®brinopeptides A and B (class AB) from ®brinogen (Kornalik, 1990a,b) . The thrombin-like enzymes usually belong to class A. The class B enzymes generally require long periods of incubation with ®brinogen before the formation of ®brin is observed (Markland, 1983) . The thrombin-like enzyme from Bothrops insularis (Selistre & Giglio, 1987) is capable of hydrolyzing ®brinogen and producing both ®brinopeptides A and B. It should be noted that unlike thrombin, these enzymes are incapable of activating factor XIII. Thus, they hydrolyze ®brinogen to produce a soft clot i.e. non-crosslinked ®brins, which are more susceptible to the lytic action of exogeneous plasmin than the hard clots (crosslinked clots) formed by thrombin.
Intravenous injection of these thrombin-like enzymes causes rapid de®brinogenation arising from the proteolysis of ®brinogen, forming non-crosslinked ®brin monomers which are removed rapidly from circulation. Because of these physiological properties, thrombin-like enzymes act as procoagulants in vitro, converting ®brinogen to ®brin. On the other hand, they cause benign de®brination (Kornalik, 1990a,b) . Batroxobin from the venom of B. moojeni and ancrod from the venom of Agkistrodon rhodostoma are produced commercially as clinical therapeutic drugs since they prevent thrombi formation and improve blood circulation by reducing blood viscosity. The serine protease reptilase is used clinically for the quantitative determination of ®brinogen in the plasma of patients undergoing heparin treatment.
Here, we present the results of the puri®cation and crystallization of bothrombin, an enzyme from the venom of B. jararaca which releases ®brinopeptide A from ®brinogen, speci®cally cleaving Arg±Gly bonds to form a soft non-crosslinked clot, aggregates platelets in the presence of exogenous ®brinogen and activates blood coagulation factor VIII. Bothrombin shares 94% homology with batroxobin (B. moojeni), which is used clinically to screen for disturbed ®brin formation and for the quantitative determination of plasma ®brinogen. The identities between bothrombin and the plasminogen activator isolated from the venom of Trimeresurus stejnegeri and trypsin are 58 and 34%, respectively.
Methods

Purification
The crude venom from B. jararaca was obtained as a lyophilized powder from a local serpentarium. 300 mg of this was dissolved in 1 ml of buffer (20 mM sodium phosphate pH 7.8) and centrifuged at 11 000 rev min À1 for 10 min. The clear supernatant was applied to a Resource 15S (Pharmacia) column which had previously been equilibrated with the same buffer. The fraction which did not bind to this column was then applied onto a Sepharosebenzamadine CL-6B column and the unspeci®cally bound fractions were eluted by washing with 0.5 M NaCl. The serine protease bothrombin was eluted by changing the pH to 3.6 using 20 mM glycine buffer. The protein was tested for proteolytic activity and for its ability to release ®brinopeptide A.
The sample was pure as evidenced by silver stained SDS±PAGE gels and was monodispersive as demonstrated by dynamic light scattering (Dynapro 801).
Crystallization
The protein was concentrated in a microconcentrator (Amicon) to a concentration of 5.0 mg ml À1 . Crystallization was performed at 1291 K by the hanging-drop vapour-diffusion method using 24-well tissue-culture plates. Initial trials were carried out using the screens produced by Hampton Research (Jancarik & Kim, 1991) . Typically, 0.5 ml drops of protein solution were mixed with an equal amount of the screening solution. Single crystals with a minimum dimension of 0.2 mm were obtained when a 1 ml drop of the protein solution was mixed with an equal volume of a solution containing 100 mM MES pH 6.2, 10 mM zinc sulfate and 15% PEG MME 550 and equilibrated over a reservoir containg the same solution. Crystals were obtained after 6 d (Fig. 1) .
X-ray diffraction data collection
For data collection, the crystal was transferred to a mother-liquor solution containing 20% glycerol and was¯ashfrozen. X-ray diffraction data were collected at the crystallographic beamline (Polikarpov et al., 1988) at the Laborato Â rio Nacional de Luz Sincrotron (LNLS, Campinas, Brazil). The synchrotron-radiation source at LNLS was set to a wavelength of 1.54 A Ê . Diffraction data were collected from 60 images using the oscillation method. Individual frames consisted of an oscillation of 1 with a crystal-to-detector distance of 260 mm. Diffraction intensity data were measured using a MAR 345 imaging-plate detector and were reduced and processed using the HKL program suite (Otwinowski & Minor, 1997) .
Results
Examination of the systematic absences indicated that the crystals belong to the space group P2 1 2 1 2 1 , with unit-cell parameters a = 94.81, b = 115.68, c = 155.98 A Ê . Calculation of the Matthews parameter (Matthews, 1968) resulted in a V M of 2.79 A Ê 3 Da À1 , assuming the existence of six molecules of bothrombin (molecular weight 25 591 Da) in the asymmetric unit. The crystals were highly mosaic; processing of the 153 850 observations to 2.8 A Ê resulted in an R merge of 18.9% for 40 899 independent re¯ections. When only data to 3.2 A Ê was used, this resulted in an R merge of 11.1% for 26 787 independent re¯ections. The relevant data collection and processing statistics are presented in Table 1 .
Bothrombin displays 58% identity and 71% homology with the plasminogen activator isolated from the venom of T. stejnegeri, whose structure has been re®ned at 2.5 A Ê to a crystallographic residual of 17.8% (Parry et al., 1998) . However, initial trials with the atomic coordinates of this protein failed to result in a molecular-replacement solution. We are currently generating a model based on this structure to be used as a probe for molecular replacement. 3.5 (1.23) ² R merge = jIh i À hIhija hIhi, where I(h) is the observed intensity of the ith measurement of re¯ection h and hI(h)i is the mean intensity of re¯ection h calculated after scaling.
